• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压和丙型肝炎病毒感染是活体供肝移植后发生晚期肾功能不全的重要危险因素:肾活检的意义。

Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal biopsy.

作者信息

Fujinaga K, Usui M, Yamamoto N, Ishikawa E, Nakatani A, Kishiwada M, Mizuno S, Sakurai H, Tabata M, Isaji S

机构信息

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

出版信息

Transplant Proc. 2014 Apr;46(3):804-10. doi: 10.1016/j.transproceed.2013.11.103.

DOI:10.1016/j.transproceed.2013.11.103
PMID:24767353
Abstract

BACKGROUND

Late renal dysfunction (LRD) after liver transplantation develops due to several factors such as viral hepatitis, calcineurin inhibitor, diabetes mellitus, and hypertension. The aim of our study was to clarify the risk factors for LRD after living donor liver plantation (LDLT) by using simple criteria for LRD and paying special attention to the significance of renal biopsy.

PATIENTS AND METHODS

Among the 98 recipients undergoing LDLT between March 2002 and June 2008, there were 77 patients who survived more than 1 year and had been followed at our clinic. LRD was simply defined as a postoperative serum creatinine level of 1.5/L or more at any point in time after 1 year from undergoing LDLT. The perioperative risk factors for developing LRD after LDLT were analyzed by uni- and multivariate analyses, and regardless of serum creatinine level, a renal biopsy was indicated when the patient developed clinical symptoms.

RESULTS

Comparing the risk factors between 22 patients with LRD and 55 without LRD, univariate analysis revealed recipient's age, generation, hypertension, hepatitis C virus (HCV) antibody-positive, pretransplantation serum creatinine level, and graft-to-recipient weight ratio to be significant risk factors. By multivariate analysis, HCV and hypertension were selected as independent risk factors. Renal biopsy was indicated in the 4 patients with proteinuria, all of whom were positive for HCV. However, by histologic and/or electron micrographic analyses, only 1 patient was diagnosed with HCV-related membranous proliferative nephritis, 1 with diabetic nephropathy, and 2 with drug (tacrolimus) -induced renal dysfunction.

CONCLUSION

Although HCV and hypertension were determined to be independent risk factors for LRD after LDLT, a renal biopsy should be performed when clinical symptoms develop regardless of creatinine levels to provide appropriate treatment.

摘要

背景

肝移植术后晚期肾功能不全(LRD)的发生是由多种因素引起的,如病毒性肝炎、钙调神经磷酸酶抑制剂、糖尿病和高血压。我们研究的目的是通过使用LRD的简单标准并特别关注肾活检的意义,来阐明活体肝移植(LDLT)后LRD的危险因素。

患者与方法

在2002年3月至2008年6月期间接受LDLT的98例受者中,有77例存活超过1年并在我们诊所接受随访。LRD被简单定义为LDLT术后1年任何时间点血清肌酐水平达到1.5mg/dL或更高。通过单因素和多因素分析对LDLT术后发生LRD的围手术期危险因素进行分析,并且无论血清肌酐水平如何,当患者出现临床症状时均进行肾活检。

结果

比较22例LRD患者和55例无LRD患者的危险因素,单因素分析显示受者年龄、代次、高血压、丙型肝炎病毒(HCV)抗体阳性、移植前血清肌酐水平以及移植物与受者体重比是显著危险因素。通过多因素分析,HCV和高血压被选为独立危险因素。4例蛋白尿患者接受了肾活检,所有患者HCV均为阳性。然而,通过组织学和/或电子显微镜分析,仅1例患者被诊断为HCV相关的膜增生性肾炎,1例为糖尿病肾病,2例为药物(他克莫司)引起的肾功能不全。

结论

虽然HCV和高血压被确定为LDLT术后LRD的独立危险因素,但无论肌酐水平如何,当出现临床症状时均应进行肾活检以提供适当的治疗。

相似文献

1
Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal biopsy.高血压和丙型肝炎病毒感染是活体供肝移植后发生晚期肾功能不全的重要危险因素:肾活检的意义。
Transplant Proc. 2014 Apr;46(3):804-10. doi: 10.1016/j.transproceed.2013.11.103.
2
Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation.血管紧张素转换酶基因多态性对成人活体肝移植术后晚期肾功能障碍的影响。
Transplant Proc. 2016 May;48(4):1184-9. doi: 10.1016/j.transproceed.2016.02.014.
3
Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.与尸体肝移植相比,活体供体肝移植后丙型肝炎复发更为严重。
Hepatology. 2004 Sep;40(3):699-707. doi: 10.1002/hep.20357.
4
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation.活体肝移植后新发糖尿病及糖代谢进行性损害的危险因素。
Transplant Proc. 2014 Apr;46(3):865-9. doi: 10.1016/j.transproceed.2013.12.027.
5
Early postoperative renal dysfunction in the adult living donor liver transplantation.成人活体肝移植术后早期肾功能障碍
Transplant Proc. 2007 Jun;39(5):1517-9. doi: 10.1016/j.transproceed.2006.11.018.
6
Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.肝移植后影响肾功能的因素。国际观察性研究MOST的结果。
Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28.
7
Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.使用抗丙型肝炎病毒包膜2单克隆抗体对活体肝移植后复发性丙型肝炎的肝移植组织进行免疫组织化学染色。
J Gastroenterol Hepatol. 2009 Apr;24(4):574-80. doi: 10.1111/j.1440-1746.2008.05638.x.
8
Diabetes mellitus after living donor liver transplantation: data from mainland China.活体肝移植后糖尿病:来自中国大陆的数据。
Transplant Proc. 2009 Jun;41(5):1756-60. doi: 10.1016/j.transproceed.2009.01.099.
9
Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.慢性病毒性肝炎对沙特肾移植患者移植肾存活的影响。
Nephron Clin Pract. 2006;102(2):c72-80. doi: 10.1159/000089090. Epub 2005 Oct 20.
10
Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.活体肾移植后移植后糖尿病的临床流行病学研究
Exp Clin Transplant. 2008 Mar;6(1):42-7.

引用本文的文献

1
Metabolic disorders and hepatitis: Insights from a Mendelian randomization study.代谢紊乱与肝炎:孟德尔随机化研究的见解
World J Gastrointest Surg. 2024 Jun 27;16(6):1775-1790. doi: 10.4240/wjgs.v16.i6.1775.
2
Renal histopathological lesions after liver transplantation: What can we find besides calcineurin inhibitor-induced nephrotoxicity?肝移植后的肾脏组织病理学病变:除了钙调磷酸酶抑制剂诱导的肾毒性之外,我们还能发现什么?
BMC Nephrol. 2022 Sep 30;23(1):324. doi: 10.1186/s12882-022-02952-y.
3
Clinical Relevance of Kidney Biopsy in Patients Qualified for Liver Transplantation and After This Procedure in the Model for End-stage Liver Disease (MELD) Era: Where Are We Today?
肝移植适应证患者和终末期肝病模型(MELD)时代肝移植术后行肾活检的临床意义:我们今天处于什么位置?
Ann Transplant. 2020 Oct 20;25:e925891. doi: 10.12659/AOT.925891.
4
Expert consensus on management of metabolic disease in Chinese liver transplant recipients.中国肝移植受者代谢病管理专家共识。
World J Gastroenterol. 2020 Jul 21;26(27):3851-3864. doi: 10.3748/wjg.v26.i27.3851.
5
Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.比较尸体供肝和活体供肝肝移植的10年肾脏转归情况。
Clin Transplant. 2015 Dec;29(12):1140-7. doi: 10.1111/ctr.12639. Epub 2015 Nov 5.